VHT — Volpara Health Technologies Income Statement
0.000.00%
Last trade - 00:00
- AU$289.99m
- AU$279.10m
- NZ$35.01m
- 74
- 14
- 96
- 65
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5 | 12.6 | 19.7 | 26.1 | 35 |
Cost of Revenue | |||||
Gross Profit | 4.13 | 10.8 | 18.1 | 23.8 | 32.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 17.2 | 35.6 | 39.2 | 42.3 | 46.2 |
Operating Profit | -12.2 | -23 | -19.4 | -16.2 | -11.2 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -11.8 | -22.3 | -18.9 | -16.2 | -11.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11.7 | -20.4 | -17.5 | -16.4 | -9.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -11.7 | -20.4 | -17.5 | -16.4 | -9.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -11.7 | -20.4 | -17.5 | -16.4 | -9.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.067 | -0.094 | -0.069 | -0.068 | -0.037 |